Reduction of gene expression by a hairpin-loop structured oligodeoxynucleotide: Alternative to siRNA and antisense

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 10, 2009, Pages 1170-1178

  Kwok, Terry ^a   Heinrich, Jochen ^a   Jung Shiu, Jiunshan ^a   Meier, Michelle G ^a   Mathur, Srikanth ^a   Moelling, Karin ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Institute for Advanced Study Berlin   (Germany)

Author keywords

Antisense; Gene silencing; Polypurine tract; Reverse transcriptase RNase H; siRNA

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; HAIRPIN LOOP STRUCTURED OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE; RIBONUCLEASE; RIBONUCLEASE H; RIBONUCLEASE H2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS RNA;

5' UNTRANSLATED REGION; ARTICLE; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION REGULATION; GENE INSERTION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROLYSIS; IN VITRO STUDY; MAMMAL CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REPORTER GENE; VIRUS INHIBITION; VIRUS LOAD;

BASE SEQUENCE; CELL LINE; CELL LINE, TRANSFORMED; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; HYDROLYSIS; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; POLY U; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE H; RNA, SMALL INTERFERING; RNA, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

EID: 69949105953     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.05.017     Document Type: Article

References (47)

1. R.J. Crouch, J.J. Toulme, Ribonucleases H, in: INSERM (Ed.), Paris, 1998, pp. 39-66.
2. Hansen J., Schulze T., Moelling K., and RNase H. activity associated with bacterially expressed reverse transcriptase of human T-cell lymphotropic virus III/lymphadenopathy-associated virus. J. Biol. Chem. 262 (1987) 12393-12396
3. Sarafianos S.G., Das K., Tantillo C., Clark Jr. A.D., Ding J., Whitcomb J.M., Boyer P.L., Hughes S.H., and Arnold E. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 20 (1996) 1449-1461
4. Jendis J., Strack B., and Moelling K. Inhibition of replication of drug-resistant HIV type 1 isolates by polypurine tract-specific oligodeoxy-nucleotide TFO A AIDS Res. Hum. Retroviruses 14 (1998) 999-1005
5. Jendis J., Strack B., Volkmann S., Boni J., and Moelling K. Inhibition of replication of fresh HIV type 1 patient isolates by a polypurine tract-specific self-complementary oligodeoxynucleotide, AIDS Res. Hum. Retroviruses 12 (1996) 1161-1168
6. Matskevich A.A., iogas A., Heinrich J., Quast S.A., and Moelling K. Short partially double-stranded oligodeoxynucleotide induces reverse transcriptase/RNase H-mediated cleavage of HIV RNA and contributes to abrogation of infectivity of virions, AIDS Res. Hum. Retroviruses 22 (2006) 1220-1230
7. Moelling K., Abels S., Jendis J., Matskevich A., and Heinrich J. Silencing of HIV by hairpin-loop-structured DNA oligonucleotide. FEBS Lett. 580 (2006) 3545-3550
8. Moelling K., Matskevich A., Elzaouk L., Heinrich J., Jung J.S., Kwok T., and Mathur S. Self-inactivation of HIV by its own RT/RNase H. Retrovirology 3 (2007) S57
9. Wöhrl B.M., and Moelling K. Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids. Biochemistry 29 (1990) 10141-10147
10. Nowotny M., Gaidamakov S.A., Crouch R.J., and Yang W. Crystal structures of RNase H bound to an RNA/DNA hybrid: substrate specificity and metal-dependent catalysis. Cell 121 (2005) 1005-1016
11. Wu H., Lima W.F., Yhang H., Fan A., Sun H., and Crooke S.T. Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs. J. Biol. Chem. 279 (2004) 17181-17189
12. Qiu J., Qian Y., Frank P., Wintersberger U., and Shen B. Saccharomyces cerevisiae RNase H(35) functions in RNA primer removal during lagging-strand DNA synthesis, most efficiently in cooperation with Rad27 nuclease. Mol. Cell. Biol. 19 (1999) 8361-8371
13. Crow Y.J., Leitch A., Hayward B.E., Garner A., Parmar R., Griffith E., Ali M., Semple C., Aicardi J., Babul-Hirji R., Baumann C., Baxter P., Bertini E., Chandler K.E., Chitayat D., Cau D., Dery C., Fazzi E., Goizet C., King M.D., Klepper J., Lacombe D., Lanzi G., Lyall H., Martinez-Frias M.L., Mathieu M., McKeown C., Monier A., Oade Y., Quarrell O.W., Rittey C.D., Rogers R.C., Sanchis A., Stephenson J.B., Tacke U., Till M., Tolmie J.L., Tomlin P., Voit T., Weschke B., Woods C.G., Lebon P., Bonthron D.T., Ponting C.P., and Jackson A.P. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat. Genet. 38 (2006) 910-916
14. Hostomsky Z., Hostomska Z., Hudson G.O., Moomaw E.W., and Nodes B.R. Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 1148-1152
15. Nowotny M., Gaidamakov S.A., Ghirlando R., Cerritelli S.M., Crouch R.J., and Yang W. Structure of human RNase H1 complexed with an RNA/DNA hybrid: insight into HIV reverse transcription. Cell 28 (2007) 264-276
16. Ben-Artzi H., Zeelon E., Le-Grice S.F., Gorecki M., and Panet A. Characterization of the double stranded RNA dependent RNase activity associated with recombinant reverse transcriptases. Nucleic Acids Res. 20 (1992) 5115-5118
17. Mizrahi V., Brooksbank R.L., and Nkabinde N.C. Mutagenesis of the conserved aspartic acid 443, glutamic acid 478, asparagines 494 and aspartic acid 498 residues in the ribonuclease H domain of p66/p51 human immunodeficiency virus type I reverse transcriptase. J. Biol. Chem. 269 (1994) 19245-19249
18. Boyer P.L., Ferris A.L., and Hughes S.H. Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J. Virol. 66 (1992) 1031-1039
19. Li X., Zhao X., Fang Y., Jiang X., Duong T., Fan C., Huang C.C., and Kain S.R. Generation of destabilized green fluorescent protein as a transcription reporter. J. Biol. Chem. 273 (1998) 34970-34975
20. Pileur F., Toulme J.J., and Cazenave C. Eukaryotic ribonucleases HI and HII generate characteristic hydrolytic patterns on DNA-RNA hybrids: further evidence that mitochondrial RNase H is an RNase HII. Nucleic Acid Res. 28 (2000) 3674-3683
21. Broccoli S., Rallu F., Sanscartier R., Cerritelli S.M., Crouch R.J., and Drolet M. Effects of RNA polymerase modifications on transcription-induced negative supercoiling and associated R-loop formation. Mol. Microbiol. 52 (2004) 1769-1779
22. Cerritelli S.M., Frolova E.G., Feng C., Grinberg A., Love P.E., and Crouch R.J. Failure to produce mitochondrial DNA results in embryonic lethality in Rnaseh1 null mice. Mol. Cell 11 (2003) 807-815
23. Crooke S.T. Progress in antisense technology. Annu. Rev. Med. 55 (2004) 61-95
24. ten Asbroek A.L., van Groenigen M., Nooij M., and Baas F. The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides. Eur. J. Biochem. 269 (2002) 583
25. Pileur F., Andreola M.L., Dausse E., Michel J., Moreau S., Yamada H., Gaidamakov S.A., Crouch R.J., Toulme J.J., and Cazenave C. Selective inhibitory DNA aptamers of the human RNase H1. Nucleic Acids Res. 31 (2003) 5776-5788
26. Cazenave C. Ribonucleases H of oocytes from the South-African clawed toad Xenopus laevis. In: Crouch R.J., and Toulmé J.J. (Eds). Ribonucleases H (1998), John Libbey, Paris 101-112
27. Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G., and Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell. 23 (2004) 185-197
28. Miller P.S. Development of antisense and antigene oligonucleotide analogs. Prog. Nucleic Acid Res. Mol. Biol. 52 (1996) 261-291
29. Crooke S.T. Progress in antisense technology. Ann. Rev. Med. 55 (2004) 61-95
30. Toulme J.J., and Helene C. Antimessenger oligodeoxyribonucleotides: an alternative to antisense RNA for artificial regulation of gene expression-a review. Gene 72 (1988) 51-58
31. Corey D.R. RNA learns from antisense. Nat Chem Biol 3 (2007) 8-11
32. Kuwasaki T., Hosono K., Takai K., Ushijima K., Nakashima H., Saito T., Yamamoto N., and Takaku H. Hairpin antisense oligonucleotides containing 2′-methoxynucleosides with base-pairing in the stem region at the 3′-end: penetration, localization, and Anti-HIV activity. Biochem. Biophys. Res. Commun. 228 (1996) 623-631
33. Boiziau C., Thuong N.T., and Toulme J.J. Mechanisms of the inhibition of reverse transcription by antisense oligonucleotides. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 768-772
34. Boiziau C., Tarrago-Litvak L., Sinha N.D., Moreau S., Litvak S., and Toulme J.J. Antisense oligonucleotides inhibit in vitro cDNA synthesis by HIV-1 reverse transcriptase. Antisense Nucleic Acid Drug Dev. 6 (1996) 103-109
35. S. Tyagi, Kramer, F. R, High specificity hairpin antisense oligonucleotides, Patent WO/2000/071740 (1999).
36. Matzen K., Elzaouk L., Matskevich A.A., Nitzsche A., Heinrich J., and Moelling K. RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides. Nat. Biotechnol. 25 (2007) 669-674
37. Kwok T., Helfer H., Alam M.I., Heinrich J., Pavlovic J., and Moelling K. Inhibition of influenza A virus replication by short double-stranded oligodeoxynucleotides. Arch Virol 154 (2009) 109-114
38. Eckstein F. The versatility of oligonucleotides as potential therapeutics. Expert Opin. Biol. Ther. 7 (2007) 1021-1034
39. Yamakawa H., Abe T., Saito T., Takai K., Yamamoto N., and Takaku H. Properties of nicked and circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligodeoxynucleotides. Bioorg. Med. Chem. 6 (1998) 1025-1032
40. Tang J.Y., Temsamani J., and Agrawal S. Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity. Nucleic Acids Res. 21 (1993) 2729-2735
41. Falkenhagen A., Heinrich J., and Moelling K. Short hairpin-loop-structured oligodeoxynucleotides reduce HSV-1 replication. Virology J. (2009)
42. Noreen F., Heinrich J., and Moelling K. Anti-tumor activity of small double-stranded oligodeoxynucleotides targeting telomerase RNA in malignant melanoma cells. Oligonucleotides (2009)
43. Good L. Translation repression by antisense sequences. Cell Mol. Life Sci. 60 (2003) 854-861
44. Mergny J.L., Li J., Lacroix L., Amrane S., and Chaires J.B. Thermal difference spectra: a specific signature for nucleic acid structures. Nucleic Acids Res (2005) 33
45. Vickers T.A., Koo S., Bennett C.F., Crooke S.T., Dean N.M., and Baker B.F. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J. Biol. Chem. 278 (2003) 7108-7118
46. Schweneker M., Bachmann A.S., and Moelling K. JM4 is a four-transmembrane protein binding to the CCR5 receptor. FEBS Lett. 579 (2005) 1751-1758
47. Moelling K., Matskevich A., and Jung J.S. Relationship between retroviral replication and RNA interference machineries. Cold Spring Harbor Symp. Quant. Biol. 71 (2006) 365-368